> Many of America’s most critical sectors, such as healthcare, are especially slow to adopt due to a variety of factors, including distrust or lack of understanding of the technology, a complex regulatory landscape, and a lack of clear governance and risk mitigation standards. A coordinated Federal effort would be beneficial in establishing a dynamic, “try-first” culture for AI across American industry. I'm sure "mov…
It probably would if you quantify risk correctly. I'm not likely to die from some experimental drug gone wrong, but extremely likely to die from some routine cause like cancer, heart disease, or other disease of old age. If I trade off an increase in risk from dying from some experimental treatment gone wrong for faster development of treatments that can delay or prevent routine causes of death, I will come out ahead in the trade unless the tradeoff ends up being extremely steep in favor of risk from bad treatments.
But that outcome is very unlikely because for this to be the case the bad treatments would have to actually harmful instead of just ineffective (which is much more common). And it also fails to take into account the possibility that there isn't even a tradeoff and AI actually makes it less likely that I will die by experimental treatment gone wrong or other medical mistake, so it's just a win-win. And there is already evidence that AI outperforms doctors in the emergency room. https://pmc.ncbi.nlm.nih.gov/articles/PMC11263899/